The AACR Minority-Serving Institution Faculty Scholar Awards in Cancer Research is supported by a grant from the National Cancer Institute's Comprehensive Minority Biomedical Program.
Awardees are chosen by an Advisory Committee of the AACR. Candidates must have completed doctoral studies or clinical fellowships relevant to cancer research and hold full-time faculty positions at the level of assistant professor or above at an institution designated as minority-serving. Candidates also must be engaged in meritorious basic, clinical, or translational cancer research.
A total of four faculty at Minority-Serving Institutions have received awards from AACR and attended Special Conferences, "Regulation of Cell Death in Oncogenesis," and "Oncogenomics 2005: Dissecting Cancer Through Genome Research."
Winners are as listed below.
"Regulation of Cell Death in Oncogenesis,"
January 26-30, 2005 Hilton Waikoloa Village, Waikoloa, Hawaii
Chien-an A. Hu, Ph.D., Assistant Professor, University of New Mexico, Albuquerque, N.M.
Duane E. Johnson, Ph.D., Director of Research, Dillard University, New Orleans, La.
KiTani, A. Parker-Johnson, Ph.D., Assistant Professor, Dillard University, New Orleans, La.
"Oncogenomics 2005: Dissecting Cancer Through Genome Research,"
February 2-6, 2005, Omni San Diego Hotel, San Diego, CA
Ronald D. Thomas, Ph.D., Associate Professor, Florida A&M University, Tallahassee, Fla.
Founded in 1907, the American Association for Cancer Research is a professional society of more than 24,000 laboratory, translational, and clinical scientists engaged in all areas of cancer research in the United States and in more than 60 other countries. AACR's mission is to accelerate the prevention and cure of cancer through research, education, communication, and advocacy. Its principal activities include the publication of five major peer-reviewed scientific journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention. AACR's Annual Meeting attracts more than 15,000 participants who share new and significant discoveries in the cancer field. Specialty meetings, held throughout the year, focus on the latest developments in all areas of cancer research.